X T L Biopharmaceuticals Ltd Adr stock is traded at $1.66, with a volume of 5,807. It is down -2.64% in the last 24 hours and down -13.54% over the past month. XTL Biopharmaceuticals Ltd is an intellectual property-based company focused on the development, management, and commercialization of intellectual property. The Company is engaged in biotechnology through its subsidiary Psyga Bio and in the biopharmaceutical industry with hCDR1, a novel compound working via a novel mechanism of action for the treatment of Systemic Lupus Erythematosus (SLE) and a potential treatment for Sjogren's syndrome (SS). It focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product candidates for the treatment of unmet clinical needs.
Previous Close:
$1.71
Open:
$1.64
24h Volume:
5,807
Relative Volume:
0.62
Market Cap:
$4.08M
Revenue:
$453.80K
Net Income/Loss:
-$1.03M
P/E Ratio:
-
EPS:
-$0.7184
Net Cash Flow:
-$717.00K
1W Performance:
-2.92%
1M Performance:
-13.54%
6M Performance:
-36.40%
1Y Performance:
-57.22%
1-Day Range:
$1.60$1.68
1-Week Range:
$1.52$2.10
52-Week Range:
$1.52$14.56
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS